Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
641.02B
Market cap641.02B
Price-Earnings ratio
30.90
Price-Earnings ratio30.90
Dividend yield
1.96%
Dividend yield1.96%
Average volume
9.39M
Average volume9.39M
High today
$268.60
High today$268.60
Low today
$265.82
Low today$265.82
Open price
$268.60
Open price$268.60
Volume
955.58K
Volume955.58K
52 Week high
$269.43
52 Week high$269.43
52 Week low
$154.21
52 Week low$154.21

Stock Snapshot

With a market cap of 641.02B, Johnson & Johnson(JNJ) trades at $266.29. The stock has a price-to-earnings ratio of 30.90 and currently yields dividends of 1.96%.

As of 2026-07-08, Johnson & Johnson(JNJ) stock has fluctuated between $265.82 and $268.60. The current price stands at $266.29, placing the stock +0.2% above today's low and -0.9% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 955.58K, compared to an average daily volume of 9.39M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.21.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.21.

JNJ News

TipRanks 2h
Johnson & Johnson price target raised to $284 from $283 at Morgan Stanley

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Johnson & Johnson to $284 from $283 and keeps an Overweight rating on the shares. Biotech...

24/7 Wall St. 3h
How A 2.5% Yield Can Turn Into A Retirement Paycheck That Keeps Growing

How A 2.5% Yield Can Turn Into A Retirement Paycheck That Keeps Growing By Drew Wood Published Jul 8, 7:11AM EDT Quick Read Replacing $80,000 in annual retire...

How A 2.5% Yield Can Turn Into A Retirement Paycheck That Keeps Growing
Simply Wall St 6h
Johnson & Johnson Highlights IMAAVY Data, Is The Stock Above Fair Value?

Johnson & Johnson (JNJ) is back in focus after releasing detailed IMAAVY data in generalized myasthenia gravis at the European Academy of Neurology Congress, wh...

Johnson & Johnson Highlights IMAAVY Data, Is The Stock Above Fair Value?

Analyst ratings

69%

of 26 ratings
Buy
69.2%
Hold
26.9%
Sell
3.8%

More JNJ News

24/7 Wall St. 18h
The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later

The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later By Drew Wood Published Jul 7, 4:23PM EDT Quick Read A 3.5% yield growing...

The Dividend Growth Snowball: How Modest Income Today Can Become Serious Income Later
CNBC 1d
George E. Johnson, founder of pioneering Black hair products company, dead at 99 - CNBC

...

George E. Johnson, founder of pioneering Black hair products company, dead at 99 - CNBC
24/7 Wall St. 1d
The $1,500-A-Month Portfolio: Conservative, Moderate, And High-Yield Paths Compared

The $1,500-A-Month Portfolio: Conservative, Moderate, And High-Yield Paths Compared By Drew Wood Published Jul 7, 6:39AM EDT Quick Read Generating $1,500 mont...

The $1,500-A-Month Portfolio: Conservative, Moderate, And High-Yield Paths Compared
Investor's Business Daily 2d
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings

IBD Stock Of The Day Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings Licensing Johnson & Johnson Johnson & Johnson JNJ $ 256.74 $6.30...

Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings
Benzinga 2d
Johnson & Johnson Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Johnson & Johnson (NYSE:JNJ) will release its second quarter earnings report before the opening bell on Wednesday, July 15. Analysts expect the New Brunswick,...

Johnson & Johnson Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
24/7 Wall St. 3d
How To Turn A Portfolio Into $500 A Month Without Chasing Dangerous Yields

How To Turn A Portfolio Into $500 A Month Without Chasing Dangerous Yields By Drew Wood Published Jul 5, 9:52AM EDT Quick Read Generating $500 a month from di...

How To Turn A Portfolio Into $500 A Month Without Chasing Dangerous Yields
Simply Wall St 3d
Johnson & Johnson Stock Looks Undervalued On Cash Flow While Earnings Look Fair

Johnson & Johnson stock has delivered a strong 80.3% return over the last three years, yet the valuation checks send a mixed message, with the Discounted Cash F...

Johnson & Johnson Stock Looks Undervalued On Cash Flow While Earnings Look Fair

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.